Vote for Proposal 2: Call toll-free at 800-574-6217

Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
07.07.21
OpGen Announces Partial Adjournment of Annual Meeting
06.30.21
OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum
06.28.21
OpGen Group Company Ares Genetics Presents R&D Pipeline Updates

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events